CellMax Life
Business Services · California, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
1271 Oakmead Pkwy, Sunnyvale, California...Phone Number
(650) 564-3905Website
www.cellmaxlife.comRevenue
$15.3 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
2
1
1
About CellMax Life
CellMax Life has developed the first non-invasive blood test for the early detection and prevention of colon cancer. Their proprietary technology is optimized for identifying precancerous adenomas, which can significantly reduce mortality rates from colorectal cancer. The company aims to make cancer prevention routine, empowering individuals to take control of their health. With millions of Americans recommended for routine screening, their breakthrough tests have the potential to save countless lives.Explore more
CellMax Life Org Chart
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is CellMax Life your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if CellMax Life has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Check out if CellMax Life is spiking on competitors!
Product Launch: Get notified when CellMax Life launches new products
Congratulate Masked Content for being promoted to Masked Content at CellMax Life
Funding: Get notified immidiatlly once CellMax Life has new funding data
CellMax Life, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if CellMax Life had a recent Job posting/layoffs
Earning: See what the market has to say on CellMax Life recently announced quarterly report
Recommended Actions
Find VP level buyers at CellMax Life
Find more new buyers
Compare Similar Companies to CellMax Life
Compare insights from companies similar to CellMax Life, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
CellMax Life is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
CellMax Life is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about CellMax Life.
CellMax Life financials insights
Gather financial insights about CellMax Life, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2016
Series A
$9M
2020
Debt
$150K
2021
Debt
$340K
CellMax Life Tech Stack
A closer look at the technologies used by CellMax Life
See more technologies
CellMax Life News & Media
CellMax Life Announces Expansion of GI Medical Advisory Board
Renowned industry experts support the company as it prepares for premarket approval studies - www.prweb.comCellMax Life Announces Positive Results From Prospective Multisite Study of Novel Blood Test to Detect Colorectal Cancer and Pre-Cancer
Data shows 92% sensitivity for colorectal cancer and 55% sensitivity for precancerous advanced adenomas at 91% specificity. Data to be presented at ASCO Gastrointestinal Cancers Symposium (PRWeb January 18, 2023) Read the full story at https://www.prweb.com/releases/2023/1/prweb19120238.htmCellMax Life Earns FDA Breakthrough Device Designation for Colon Cancer & Pre-Cancerous Adenomas Screening Blood Test
FirstSight™ Now Qualifies for Expedited FDA Review Process as a Blood Test for Detection of Advanced Neoplasia (Colorectal Cancer & Pre-Cancerous Advanced Adenomas) FirstSight™ Now Qualifies for Expedited FDA Review Process as a Blood Test for Detection of Advanced Neoplasia (Colorectal Cancer & Pre-Cancerous Advanced Adenomas)CellMax Life and Sebela Pharmaceuticals Enter Strategic Development and Commercialization Partnership for FirstSight™ Blood Test for Detection of Colorectal Cancer and Pre-Cancer
SUNNYVALE, Calif. and ROSWELL, Ga., March 23, 2021 /PRNewswire/ -- CellMax Life, a molecular diagnostics company with proprietary technology for pre-cancer and cancer detection blood tests, and Sebela Pharmaceuticals, a market leader in gastroenterology, announce the closing of a...
Read more news
Top Business Services Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding CellMax Life
Sign Up For FreeTo access detailed company insights
CellMax Life has developed the first non-invasive blood test for the early detection and prevention of colon cancer. Their proprietary technology is optimized for identifying precancerous adenomas, which can significantly reduce mortality rates from colorectal cancer. The company aims to make cancer prevention routine, empowering individuals to tak... Read More
